Mar 29, 2017
The cornerstone to a successful negotiation is strong internal alignment on the objectives and structure for a deal. More often than not, companies will enter into a negotiation process in a reactionary position and gloss over, or skip entirely, the internal...
Mar 23, 2017
I recently had the pleasure to conduct a podcast conversation with Bradley Campbell, who is the President and Chief Operating Officer of Amicus Therapeutics (listen to the podcast here). Bradley recounted the interesting history of Amicus’ development of Galafold™...
Mar 15, 2017
With the election of President Trump and a Republican congress last November, many (including Locust Walk) have speculated on the future of pricing, reimbursement, drug approval and other potential policy changes and their potential impact on the biopharma industry....
Mar 3, 2017
Locust Walk’s Andy Meyerson will participate in a life sciences “Shark Tank” panel at the upcoming Life Sciences Night on March 30, sponsored by Venture Café Foundation. Life Sciences Night will feature the latest business, technology, and regulatory developments in...
Mar 2, 2017
The FDA Amendments Act of 2007 created an incentive system for drug developers to pursue tropical neglected diseases, whereby upon approval of a product for a designated tropical disease, the drug developer would receive a voucher that could be applied to receive a...
